Industry News


Industry News
Global Trends
Events Calendar
Web Links

Web Gallery

Advertising  Info



Medical Device Industry Demands Separate Marketing Practices Code Different From Pharma Industry

As the characteristics of the medical device industry are different from the pharmaceutical industry, the medical device industry has sought a separate marketing practices code for the medical devices industry.

The medical devices industry associations raised this issue at a review meeting held by the Department of Pharmaceuticals (DoP) on August 21, 2020, to review implementation of the Uniform Code of Pharmaceutical Marketing Practices (UCPMP). The meeting, held through video conferencing, was chaired byDoP secretary Dr P D Vaghela.

“The characteristics of the medical device industry are somewhat different from the pharma industry and though the associations have requested in earlier meetings to have a separate code for the medical devices industry, AiMeD is in agreement with the government to start with pharma defined code first but with some changes. Innovative and high-end medical devices such as robotics require proper training to impart skills to users unlike drugs. However, training can be given ethically with no lavish conferences and free travel to exotic tourist destinations,” stated Rajiv Nath, forum coordinator, Association of Indian Medical Device Industry (AiMeD) further adding that AiMeD has uploaded UCPMP on its website and formed the ethics committee as well as held meetings, invited suggestions and complaints from its members.

“Ethical marketing is being a challenge in India of medical devices if manufacturers and importers use artificially inflated high maximum retail price (MRP) high trade margins to induce hospitals and retailers to push their products. We have been seeking that MRP should not be over four to five times of import landed price or ex factory price (on which GST is charged initially) instead of prevailing MRP that go up to 20 times," Nath further added.

The orthopaedic implant Industry is challenged by the co existence of hundreds unlicensed manufacturers of implants that are allowed to market their unlicensed implant without regulatory approval which creates an unethical and unfair marketplace, stated Anu Dureja of Siora Surgicals and AiMeD member.

“Exorbitantly high demands for sponsorships by doctors, hospitals has been challenging for us” stated Kanwar Sehgal of Endomed Technologies. “These huge expenses can’t be matched by the small and midsize segment of the medical devices industry and denies access of affordable Indian products to Indian patients,” he explained.

The DoP secretary had asked all the associations including medical devices to implement UCPMP. Secretary (DoP) showed his displeasure at the status of implementation of UCPMP and exhorted all associations to implement the code without exception. He mentioned that suggestions can be discussed in separate meetings under JS (Policy) to be called next week for medical Devices separately. He also asked the associations to quote exact provisions of laws of other countries as precedence and reference while giving suggestions in respect of UCPMP.

Despite government mandate on UCPMP and as envisaged by DoP, details have not been uploaded related to the Ethics Committee for Pharma Marketing Practices (ECPMP) and Apex Ethics Committee for Pharmaceuticals Marketing Practices (AECPMP) of all the associations along with contact number and procedure of filing complaints on the website of DoP.

To review the implementation of the voluntary UCPMP, all the associations (Pharmaceuticals and medical devices) are requested to provide the details of their Ethics Committee for Pharma Marketing Practices (ECPMP) and Apex Ethics Committee for Pharmaceuticals Marketing Practices (AECPMP) along with contact numbers and procedure of filing complaint so that the same can be uploaded on the website of DoP.

A meeting to review the implementation of UCPMP was held under the chairmanship of Secretary (DoP) on February 17, 2020. Secretary, DoP enquired how many associations have uploaded the UCPMP on their website and have formed the two Committees. , August 24, 2020.

COVID-19 Treatment: CDSCO Shows Green Flag To Baxter India Oxiris Filter

Gurugram: Healthcare firm Baxter India on Tuesday said it has received approval from the Central Drugs Standard Control Organisation (CDSCO) for the use of its Oxiris blood purification filter for the treatment of Covid-19 patients.

The filter is intended to be used in the critically ill Covid-19 patients in need of blood purification where excessive inflammatory mediators are present, Baxter India said in a statement.

"The Covid-19 cases in India have been spiralling and putting pressure on our the healthcare system. This approval has come at a crucial time when such filter sets are much required to ease the burden on healthcare providers," Baxter India General Manager Ravinder Dang said.

The company hopes that the availability of Oxiris will go a long way in fighting the Covid-19 cases in India, he added.

During blood purification therapy, the patient's blood passes through the Oxiris filter set, where it can adsorb inflammatory mediators, and remove fluid, electrolytes and uremic toxins, before returning the patient's blood to the body, Baxter India said.

Baxter India is a wholly-owned subsidiary of Baxter International Inc. It started operations in India in April 1997. , July 8, 2020

Other News

Hindustan Syringes Sends Over 56 Million Pieces to Covax Facility
Japan Commits Rs 3500Cr To Strengthen Indian Health Sector
SCTIMST inks MoU with Tynor Orthotic to boost orthotic devices
IPC Rolls Out PPE Adverse Event Reporting Form As Part Of MvPI For Patient And Health Worker Safety
NATHEALTH and APACMED join hands to advance medical technology for UHC in India
Kraton’s BIAXAM kills up to 99.99% of microbes including SARS-CoV-2
Medical device importers ask govt to incentivize innovations for economies of scale for affordability
Goa hopes to qualify for medical device park, appoints consultant
Kerala to have one of the first medical device parks
German glassmaker SCHOTT AG appoints Pawan Kumar Shukla as MD
MEDICA and COMPAMED go virtual
Anti-bacterial film developed for touchscreen medical devices
Messe Frankfurt India plans to launch Medical Device Innovation Summit as large format event in 2020
Best time to invest in pharma, medical device sector: DV Sadananda Gowda
CHP to offer expert consultative advice for setting up medical device and pharma parks in UP
Indian Medical Device Industry, growing faster during COVID-19 pandemic
VIEW: Untold story of Indian medtech and how to make it ‘Atmanirbhar’
Govt lifts ban on export of PPE suits, face masks, hand sanitisers
From Being A Net Importer, India Now Manufactures Over 5 Lakh PPE Kits Per Day: Union Minister Sadananda Gowda
Abbott launches heart rhythm management devices in India
Ceresana Examines the World Market for Thermoplastic elastomers





Back | Back To Top | Previous | Next